Alzheimer’s Drug Discovery Foundation
Funding rounds backed by Alzheimer’s Drug Discovery Foundation.
- Funding disclosed in full
- $5M
- Median round
- $5M
- Rounds in calculation
- 1
| Company | Round | Market | Investors | Announced | Details |
|---|---|---|---|---|---|
| MindImmune Develops immune-focused therapies for neurodegenerative diseases, including Alzheimer’s disease | $5MStrategic | BiotechUnited States | 1 participantAlzheimer’s Drug Discovery Foundation |